Heart Failure Latest Features Archive
Patients with heart failure rarely use evidence-based alternative treatments such as yoga or massage, to manage their comorbid chronic pain.
Repairing mitral regurgitation via transcatheter MitraClip has become a promising therapeutic option for high surgical risk patients.
Transcatheter aortic valve replacement continues to evolve as a treatment for patients with symptomatic severe aortic stenosis, as well as for younger, lower-risk patients.
Although surgery remains the gold standard in mitral valve repair, percutaneous repair is a new option in the treatment armamentarium, particularly in high-risk settings.
The Cardiology Advisor Articles
- Does Pre-Existing PH Affect Outcomes in Transcatheter Mitral Valve Repair?
- How Has the Medicaid Expansion Affected Patients Hospitalized With Acute MI?
- Macitentan Not Superior to Placebo for Improving Exercise Capacity in Eisenmenger Syndrome
- Occupational Metal, Pesticide Exposure May Be Associated With Increased CVD Risk
- FDA to Review Tafamidis for Treatment of Transthyretin Amyloid Cardiomyopathy
- ASH Develops Practice Guidelines for Venous Thromboembolism
- Tetralogy of Fallot: Long-Term Outcomes After Surgical Repair
- Stethoscopes in ICU Show High Levels of Bacterial Contamination
- Catheter Ablation Superior to Drug Therapy for Atrial Fibrillation in Heart Failure
- Trends in Endocarditis Incidence After Implementation of 2007 AHA Recommendations
- Researchers Identify Golden Ratio Between Pulmonary Pressure Components in PAH
- FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
- Inhaled Dry Powder Formulation of Treprostinil Well Tolerated in PAH
- Elevated Myocardial T1 Associated With Increased Septal Angle in PAH
- Pulmonary Hypertension Intensive Care Options Depend on Treatment Goals